— Publications

2017 Annual Business Report

All financial reports

— Media releases

July 2, 2018

Valneva Announces Significant Progress of its Lyme Disease Vaccine Candidate

Read more

— Financial calendar

Upcoming events
HY 2018 Financial Statements
August 2, 2018

All dates

— Meet us

Goldman Sachs 8th Annual Biotech Symposium
September 7, London

European Large & Midcap Event
October 8-9, Paris

World Vaccine Congress Europe
October 29-31, Lisbon

Stifel 2018 Healthcare Conference
Lyme Disease

Download brochure


— Our responsibility

Committed to people, protecting lives and the environment

Learn more

play video Valneva's CEO Thomas Lingelbach
comments on Group Strategy

Subscribe to our Newsletter


Contact Investor Relations


Please update your browser...